Advertisement
Screener

ANIXA BIOSCIENCES, INC. (ANIX) Stock Granted During Period, Shares, Share-based Compensation (Deprecated 2011-01-31)

2.8 / 5 stars · 68/120 Roast Me

ANIXA BIOSCIENCES, INC. Stock Granted During Period, Shares, Share-based Compensation (Deprecated 2011-01-31)

ANIXA BIOSCIENCES, INC. (ANIX) reported Stock Granted During Period, Shares, Share-based Compensation (Deprecated 2011-01-31) of 1.29 million shares for the 9-month period ending 2012-07-31, per its 10-Q filed 2012-09-14.

Discontinued › Notes › Compensation Related Costs

us-gaap:StockGrantedDuringPeriodSharesSharebasedCompensation · last filed 2012-09-14

  • 2012-07-31: Stock Granted During Period, Shares, Share-based Compensation (Deprecated 2011-01-31) 9 month 1.29M shares.
  • 2011-07-31: Stock Granted During Period, Shares, Share-based Compensation (Deprecated 2011-01-31) 9 month 4.13M shares.
Period endStock Granted During Period, Shares, Share-based Compensation (Deprecated 2011-01-31) 9 month
2012-07-311.29M shares
10-Q · filed 2012-09-14
2011-07-314.13M shares
10-Q · filed 2012-09-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ProMIS Neurosciences Inc. (PMN)$0.102B
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92